Causaly News and Activities

View the org chart displaying its 28 main executives

Most searched biographies at Causaly

• Yiannis Kiachopoulos, Co-Founder, Chief Executive Officer
• Artur Saudabayev, Co-Founder, Chief Technology Officer
• Marco Costa, Chief Operating Officer

Popular executive movements at Causaly

• Claire Henshaw-Green, Director, People Operations and Talent, has left the company  (posted on May 4 2026).
• Sapan Modi who was Senior Strategic Engagement Manager, becomes Principal Strategic Engagement Manager  (posted on May 4 2026).
• Guilherme Pinheiro has joined the company as Senior Vice President, Global Sales  (posted on November 24 2025).

Click here to view some more movements at Causaly

Create your alert
to follow the executive moves at Causaly.

Causaly has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Causaly

• Causaly announces ISO 27001 certification
• Causaly announces the appointment of Chris Tunnell as SVP Global Sales

Social media about Causaly

• Causaly on Wikipedia, Google News & Yahoo Finance
• Causaly on LinkedIn, X (Twitter) & YouTube